drugset / Trial / NCT00174629
GILT Docetaxel - Non-Small Cell Lung Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
Primary Objective: * To compare response rate between genotypic groups and control group. Secondary Objective: * To determine the safety, time to treatment failure and survival in control and genotypic arms.
Timeline
- Start
- 2001-06
- Primary completion
- 2007-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DDP | Unknown | — | — |
| Comparator | Docetaxel | Small molecule | — | — |
| Subject | Gemcitabine | Small molecule | — | — |